Antibody Optimization Services

We combine proprietary AI, in-house humanization and affinity maturation, and high-throughput screening to deliver faster, more reliable results. With up to 10–100x affinity improvement, IP-free solutions, and full integration from discovery to bioproduction, we provide unique value and the expertise to manage even the most complex projects.

Our approach blends AI-driven in silico models for rapid candidate screening, in-house engineering platforms, and high-throughput assays to enhance affinity, specificity, and stability. We also integrate developability assessments early on to predict stability, safety, and manufacturability assessments, reducing the risk of late-stage failures. This balance of computational and experimental methods allows us to deliver optimized antibodies ready for successful preclinical development.

Every client is assigned a dedicated project manager who acts as both your scientific advisor and your liaison with our research team. Your project manager provides expert guidance, translates complex data into actionable insights, and coordinates the work of our antibody engineering specialists. This ensures clear communication, expert guidance, and seamless coordination throughout your project.

Yes. At delivery, you receive a comprehensive data package and a scientific report. Our experts provide next-step recommendations, whether you wish to advance to antibody expression, characterization assays, or large-scale bioproduction. With all services available in-house, you can seamlessly continue your development journey with ProteoGenix without losing time or transferring sensitive material to another provider. This post-project support ensures continuity, reduces risks, and accelerates your path to the clinic.

Yes, ProteoGenix is one of the few providers offering an end-to-end solution covering antigen design, antibody generation, optimization, sequencing, expression, and large-scale bioproduction. This integration saves time, reduces risks, and ensures consistency across every stage. Whether you require support for a single stage or full development from start to finish, ProteoGenix provides the flexibility and expertise to accelerate your program to preclinical success.

We combine AI-powered predictive models with in vitro and in vivo assays to evaluate stability, immunogenicity, aggregation, and manufacturability early on. By identifying and addressing potential liabilities upfront, we reduce the chance of late-stage failures and costly delays. Our integrated approach ensures that optimized antibodies are not only functional and high-affinity but also safe, stable, and scalable for production.